Insider · CIK 0002009136
Robin LaChapelle
Files at AVBP (ArriVent BioPharma, Inc.). First filing -, latest -.
Robin LaChapelle files SEC Form 4 as COO at AVBP (ArriVent BioPharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robin LaChapelle has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 2, 2026 | AVBP ArriVent BioPharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +130,000 | $0.00 | $0 | 130,000 | Feb 4, 2026 |
| Jul 11, 2025 | AVBP ArriVent BioPharma, Inc. | MOption exercise Common Stock | +2,050 | $2.28 | $4,674 | 126,633 | Jul 15, 2025 |
| Jul 11, 2025 | AVBP ArriVent BioPharma, Inc. | MOption exercise Common Stock | +2,600 | $2.28 | $5,928 | 129,233 | Jul 15, 2025 |
| Jul 11, 2025 | AVBP ArriVent BioPharma, Inc. | MOption exercise Common Stock | +6,503 | $2.28 | $15k | 135,736 | Jul 15, 2025 |
| Jul 11, 2025 | AVBP ArriVent BioPharma, Inc. | MOption exercise Stock Option (right to buy)derivative | -2,050 | $0.00 | $0 | 410 | Jul 15, 2025 |
| Jul 11, 2025 | AVBP ArriVent BioPharma, Inc. | MOption exercise Stock Option (right to buy)derivative | -2,600 | $0.00 | $0 | 12,873 | Jul 15, 2025 |
| Jul 11, 2025 | AVBP ArriVent BioPharma, Inc. | MOption exercise Stock Option (right to buy)derivative | -6,503 | $0.00 | $0 | 6,370 | Jul 15, 2025 |
| Feb 3, 2025 | AVBP ArriVent BioPharma, Inc. | AGrant or award Stock Option (right to buy)derivative | +120,000 | $0.00 | $0 | 120,000 | Feb 14, 2025 |
Questions about Robin LaChapelle
Answered from the filings on this page, as of the latest one.
Is Robin LaChapelle buying or selling?
Robin LaChapelle has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robin LaChapelle's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robin LaChapelle has 0.
Where does Robin LaChapelle file Form 4?
Robin LaChapelle has filed Form 4 at AVBP (ArriVent BioPharma, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.